Statistics

Total Visits

Views
The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials127

Select a period of time:

Number of views in the range

Views
The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials47

Views

Views
November 20251
December 20251
January 20266
February 20260
March 20266
April 20266
May 202627
Download CSV file
 untranslated
 untranslated

Top country views

Views
Ireland19
United States13
Finland5
United Kingdom2
Germany2
Argentina1
Colombia1
Egypt1
France1
Mexico1
 

Top cities views

Views
Dublin19
Helsinki5
Palmyra2
Frankfurt am Main2
Giza1
Guadalajara1
La Plata1
London1
Medellín1
Paris1